AVDL AVADEL PHARMACEUTICALS PLC Legal Disputes 8-K Filing 2025 - Regulatory Compliance On May 6, 2025, Avadel Pharmaceuticals announced a favorable ruling from the U.S. Court of Appeals, allowing them to seek FDA approval for LUMRYZ for uses beyond narcolepsy, after overturning parts of a prior injunction from a Delaware court.Get access to all SEC 8-K filings of the AVADEL PHARMACEUTICALS PLC